United States Rosacea Medicine Market Report 2018

January 2018 | 100 pages | ID: UDF90DC3522EN
QYResearch

Abstracts

In this report, the United States Rosacea Medicine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Rosacea Medicine in these regions, from 2013 to 2025 (forecast).

United States Rosacea Medicine market competition by top manufacturers/players, with Rosacea Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Galderma Laboratories
• Allergan Inc.
• Topix
• Barrier Therapeutics, Inc
• Bayer AG
• PharmaDerm Pharmaceuticals, Inc
• Bristol-Myers Squibb
• Genentech, Inc.
• GlaxoSmithKline Plc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Prescription Medicine
• OTC

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Oral Administration
• External Application

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Rosacea Medicine Market Report 2018

1 ROSACEA MEDICINE OVERVIEW

1.1 Product Overview and Scope of Rosacea Medicine
1.2 Classification of Rosacea Medicine by Product Category
  1.2.1 United States Rosacea Medicine Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Rosacea Medicine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Prescription Medicine
  1.2.4 OTC
1.3 United States Rosacea Medicine Market by Application/End Users
  1.3.1 United States Rosacea Medicine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Oral Administration
  1.3.3 External Application
1.4 United States Rosacea Medicine Market by Region
  1.4.1 United States Rosacea Medicine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Rosacea Medicine Status and Prospect (2013-2025)
  1.4.3 Southwest Rosacea Medicine Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Rosacea Medicine Status and Prospect (2013-2025)
  1.4.5 New England Rosacea Medicine Status and Prospect (2013-2025)
  1.4.6 The South Rosacea Medicine Status and Prospect (2013-2025)
  1.4.7 The Midwest Rosacea Medicine Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Rosacea Medicine (2013-2025)
  1.5.1 United States Rosacea Medicine Sales and Growth Rate (2013-2025)
  1.5.2 United States Rosacea Medicine Revenue and Growth Rate (2013-2025)

2 UNITED STATES ROSACEA MEDICINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Rosacea Medicine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Rosacea Medicine Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Rosacea Medicine Average Price by Players/Suppliers (2013-2018)
2.4 United States Rosacea Medicine Market Competitive Situation and Trends
  2.4.1 United States Rosacea Medicine Market Concentration Rate
  2.4.2 United States Rosacea Medicine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Rosacea Medicine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ROSACEA MEDICINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Rosacea Medicine Sales and Market Share by Region (2013-2018)
3.2 United States Rosacea Medicine Revenue and Market Share by Region (2013-2018)
3.3 United States Rosacea Medicine Price by Region (2013-2018)

4 UNITED STATES ROSACEA MEDICINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Rosacea Medicine Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Rosacea Medicine Revenue and Market Share by Type (2013-2018)
4.3 United States Rosacea Medicine Price by Type (2013-2018)
4.4 United States Rosacea Medicine Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ROSACEA MEDICINE SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Rosacea Medicine Sales and Market Share by Application (2013-2018)
5.2 United States Rosacea Medicine Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ROSACEA MEDICINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Galderma Laboratories
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Rosacea Medicine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Galderma Laboratories Rosacea Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Allergan Inc.
  6.2.2 Rosacea Medicine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Allergan Inc. Rosacea Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Topix
  6.3.2 Rosacea Medicine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Topix Rosacea Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Barrier Therapeutics, Inc
  6.4.2 Rosacea Medicine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Barrier Therapeutics, Inc Rosacea Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Bayer AG
  6.5.2 Rosacea Medicine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bayer AG Rosacea Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 PharmaDerm Pharmaceuticals, Inc
  6.6.2 Rosacea Medicine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 PharmaDerm Pharmaceuticals, Inc Rosacea Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Bristol-Myers Squibb
  6.7.2 Rosacea Medicine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bristol-Myers Squibb Rosacea Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Genentech, Inc.
  6.8.2 Rosacea Medicine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Genentech, Inc. Rosacea Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 GlaxoSmithKline Plc
  6.9.2 Rosacea Medicine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 GlaxoSmithKline Plc Rosacea Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview

7 ROSACEA MEDICINE MANUFACTURING COST ANALYSIS

7.1 Rosacea Medicine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Rosacea Medicine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Rosacea Medicine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Rosacea Medicine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ROSACEA MEDICINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Rosacea Medicine Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Rosacea Medicine Sales Volume Forecast by Type (2018-2025)
11.3 United States Rosacea Medicine Sales Volume Forecast by Application (2018-2025)
11.4 United States Rosacea Medicine Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Rosacea Medicine
Figure United States Rosacea Medicine Market Size (K Pcs) by Type (2013-2025)
Figure United States Rosacea Medicine Sales Volume Market Share by Type (Product Category) in 2017
Figure Prescription Medicine Product Picture
Figure OTC Product Picture
Figure United States Rosacea Medicine Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Rosacea Medicine by Application in 2017
Figure Oral Administration Examples
Table Key Downstream Customer in Oral Administration
Figure External Application Examples
Table Key Downstream Customer in External Application
Figure United States Rosacea Medicine Market Size (Million USD) by Region (2013-2025)
Figure The West Rosacea Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Rosacea Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Rosacea Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Rosacea Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Rosacea Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Rosacea Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Rosacea Medicine Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Rosacea Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Rosacea Medicine Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Rosacea Medicine Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Rosacea Medicine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Rosacea Medicine Sales Share by Players/Suppliers
Figure 2017 United States Rosacea Medicine Sales Share by Players/Suppliers
Figure United States Rosacea Medicine Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Rosacea Medicine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Rosacea Medicine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Rosacea Medicine Revenue Share by Players/Suppliers
Figure 2017 United States Rosacea Medicine Revenue Share by Players/Suppliers
Table United States Market Rosacea Medicine Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Rosacea Medicine Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Rosacea Medicine Market Share of Top 3 Players/Suppliers
Figure United States Rosacea Medicine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Rosacea Medicine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Rosacea Medicine Product Category
Table United States Rosacea Medicine Sales (K Pcs) by Region (2013-2018)
Table United States Rosacea Medicine Sales Share by Region (2013-2018)
Figure United States Rosacea Medicine Sales Share by Region (2013-2018)
Figure United States Rosacea Medicine Sales Market Share by Region in 2017
Table United States Rosacea Medicine Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Rosacea Medicine Revenue Share by Region (2013-2018)
Figure United States Rosacea Medicine Revenue Market Share by Region (2013-2018)
Figure United States Rosacea Medicine Revenue Market Share by Region in 2017
Table United States Rosacea Medicine Price (USD/Pcs) by Region (2013-2018)
Table United States Rosacea Medicine Sales (K Pcs) by Type (2013-2018)
Table United States Rosacea Medicine Sales Share by Type (2013-2018)
Figure United States Rosacea Medicine Sales Share by Type (2013-2018)
Figure United States Rosacea Medicine Sales Market Share by Type in 2017
Table United States Rosacea Medicine Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Rosacea Medicine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Rosacea Medicine by Type (2013-2018)
Figure Revenue Market Share of Rosacea Medicine by Type in 2017
Table United States Rosacea Medicine Price (USD/Pcs) by Types (2013-2018)
Figure United States Rosacea Medicine Sales Growth Rate by Type (2013-2018)
Table United States Rosacea Medicine Sales (K Pcs) by Application (2013-2018)
Table United States Rosacea Medicine Sales Market Share by Application (2013-2018)
Figure United States Rosacea Medicine Sales Market Share by Application (2013-2018)
Figure United States Rosacea Medicine Sales Market Share by Application in 2017
Table United States Rosacea Medicine Sales Growth Rate by Application (2013-2018)
Figure United States Rosacea Medicine Sales Growth Rate by Application (2013-2018)
Table Galderma Laboratories Basic Information List
Table Galderma Laboratories Rosacea Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Galderma Laboratories Rosacea Medicine Sales Growth Rate (2013-2018)
Figure Galderma Laboratories Rosacea Medicine Sales Market Share in United States (2013-2018)
Figure Galderma Laboratories Rosacea Medicine Revenue Market Share in United States (2013-2018)
Table Allergan Inc. Basic Information List
Table Allergan Inc. Rosacea Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Allergan Inc. Rosacea Medicine Sales Growth Rate (2013-2018)
Figure Allergan Inc. Rosacea Medicine Sales Market Share in United States (2013-2018)
Figure Allergan Inc. Rosacea Medicine Revenue Market Share in United States (2013-2018)
Table Topix Basic Information List
Table Topix Rosacea Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Topix Rosacea Medicine Sales Growth Rate (2013-2018)
Figure Topix Rosacea Medicine Sales Market Share in United States (2013-2018)
Figure Topix Rosacea Medicine Revenue Market Share in United States (2013-2018)
Table Barrier Therapeutics, Inc Basic Information List
Table Barrier Therapeutics, Inc Rosacea Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Barrier Therapeutics, Inc Rosacea Medicine Sales Growth Rate (2013-2018)
Figure Barrier Therapeutics, Inc Rosacea Medicine Sales Market Share in United States (2013-2018)
Figure Barrier Therapeutics, Inc Rosacea Medicine Revenue Market Share in United States (2013-2018)
Table Bayer AG Basic Information List
Table Bayer AG Rosacea Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer AG Rosacea Medicine Sales Growth Rate (2013-2018)
Figure Bayer AG Rosacea Medicine Sales Market Share in United States (2013-2018)
Figure Bayer AG Rosacea Medicine Revenue Market Share in United States (2013-2018)
Table PharmaDerm Pharmaceuticals, Inc Basic Information List
Table PharmaDerm Pharmaceuticals, Inc Rosacea Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure PharmaDerm Pharmaceuticals, Inc Rosacea Medicine Sales Growth Rate (2013-2018)
Figure PharmaDerm Pharmaceuticals, Inc Rosacea Medicine Sales Market Share in United States (2013-2018)
Figure PharmaDerm Pharmaceuticals, Inc Rosacea Medicine Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Rosacea Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Rosacea Medicine Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Rosacea Medicine Sales Market Share in United States (2013-2018)
Figure Bristol-Myers Squibb Rosacea Medicine Revenue Market Share in United States (2013-2018)
Table Genentech, Inc. Basic Information List
Table Genentech, Inc. Rosacea Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genentech, Inc. Rosacea Medicine Sales Growth Rate (2013-2018)
Figure Genentech, Inc. Rosacea Medicine Sales Market Share in United States (2013-2018)
Figure Genentech, Inc. Rosacea Medicine Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Rosacea Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Plc Rosacea Medicine Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Plc Rosacea Medicine Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Plc Rosacea Medicine Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rosacea Medicine
Figure Manufacturing Process Analysis of Rosacea Medicine
Figure Rosacea Medicine Industrial Chain Analysis
Table Raw Materials Sources of Rosacea Medicine Major Players/Suppliers in 2017
Table Major Buyers of Rosacea Medicine
Table Distributors/Traders List
Figure United States Rosacea Medicine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Rosacea Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Rosacea Medicine Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Rosacea Medicine Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Rosacea Medicine Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Rosacea Medicine Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Rosacea Medicine Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Rosacea Medicine Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Rosacea Medicine Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Rosacea Medicine Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Rosacea Medicine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Rosacea Medicine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Rosacea Medicine Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources